Tofacitinib Is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis

Clin Gastroenterol Hepatol. 2021 Jun;19(6):1302-1303. doi: 10.1016/j.cgh.2020.07.046. Epub 2020 Nov 26.

Authors

Robert Gilmore¹, Patrick Hilley¹, Ashish Srinivasan², Matthew C Choy², Josephine A Grace², Peter de Cruz²

Affiliations

¹ Department of Gastroenterology, Austin Health, Melbourne, Australia.
² Department of Gastroenterology, Austin Health, Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, Australia.

PMID: 33248087
DOI: 10.1016/j.cgh.2020.07.046

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Colitis, Ulcerative* / drug therapy
Humans
Infliximab
Piperidines
Pyrimidines

Substances

Piperidines
Pyrimidines
tofacitinib
Infliximab